📰 Boxed Warning News
Page 38 - Boxed Warning News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Boxed Warning. Real-time updates on events, politics, business and more.
October 31, 2022
Largest, worldwide epilepsy community gathering will feature a physician presentation on VALTOCO® (diazepam nasal spray) CIV for frequent seizure ...
October 27, 2022
The FDA has granted accelerated approval to Tecvayli (teclistamab-cqyv) for the treatment of adults with relapsed or refractory multiple myeloma.
October 25, 2022
Teclistamab is now an option after progression on triple-class therapy; however, the FDA also issued a Boxed Warning for life-threatening or fatal cytokine release syndrome and neurologic toxicity.
October 24, 2022
/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, today announced that five scientific abstracts on the clinical...
October 24, 2022
/PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...
October 24, 2022
/PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...
October 20, 2022
Auvelity (dextromethorphan HBr-buproprion HCl) extended-release tablets are now available for the treatment of adults with MDD.
October 19, 2022
/PRNewswire/ -- Tris Pharma, Inc. (Tris) a fully integrated pharmaceutical company with a robust portfolio of CNS products announced today that DYANAVEL® XR...
October 19, 2022
Data served as basis for recent FDA approval of ruxolitinib cream (Opzelura) 1.5% for the topical treatment of nonsegmental vitiligo in adult and pediatric patients 12 years of age and older Fifty-two
October 13, 2022
/PRNewswire/ -- Neurelis, Inc., today announced findings from a novel, investigational analysis of the time between seizure clusters in pediatric patients...